Sign up to save your podcasts
Or
Share ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Late Breaker: APOLLO Trial - Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a)
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
View all episodes
By American College of Cardiology
3.8
4747 ratings
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
127 Listeners
NEJM This Week
315 Listeners
JACC Podcast
160 Listeners
This Week in Cardiology
853 Listeners
JAMA Clinical Reviews
478 Listeners
JACC Specialty Journals
22 Listeners
Circulation on the Run
31 Listeners
JAMA Medical News
91 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
134 Listeners
Core IM | Internal Medicine Podcast
1,085 Listeners
ACC CardiaCast
38 Listeners
Annals On Call Podcast
175 Listeners
Cardionerds: A Cardiology Podcast
414 Listeners
Mayo Clinic Cardiovascular CME
33 Listeners
Sensible Medicine
127 Listeners